Lung cancer: Significant progress leads to record annual decrease in cancer mortality

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

We were recently presented with the new report from American Cancer Society1 showing the biggest annual decrease in cancer mortality, which was mainly due to decline in smoking, as well as improvements in early detection and treatment.

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Fred R. Hirsch, MD, PhD
Executive director, Center for Thoracic Oncology, Tisch Cancer Institute, Mount Sinai
Professor of Medicine and Pathology, Icahn School of Medicine, Mount Sinai

YOU MAY BE INTERESTED IN

In an effort to target the right patients, genetic screening is becoming more common in clinical trials. But incorporating it can be complex and add a significant burden for both patients and clinical trial sites. Genetic counseling can streamline that process and help drug and gene therapy developers expedite the recruitment of genetically-eligible participants for their trials and use genetic testing results to accelerate the speed and success of clinical trials.
Fred R. Hirsch, MD, PhD
Executive director, Center for Thoracic Oncology, Tisch Cancer Institute, Mount Sinai
Professor of Medicine and Pathology, Icahn School of Medicine, Mount Sinai

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login